Yifei Dong

Yifei Dong

Auto-generated profile, based on publicly available information

Yifei Dong

Department of Biochemistry, Microbiology & Immunology, College of Medicine University of Saskatchewan Saskatoon Saskatchewan Canada

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
JPJason R. Plemel
Jason R. Plemel
JSJo Anne Stratton
Jo Anne Stratton
NMNathan J. Michaels
Nathan J. Michaels
KRKhalil S. Rawji
Khalil S. Rawji
EZEric Zhang
Eric Zhang
VYV. Wee Yong
V. Wee Yong
Microglia respond to white matter injury with different populations that prevent macrophage dispersion into spared tissue.

20 June 2012 in European Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DMDmitry. M. Mebel
Dmitry. M. Mebel
JWJovi. C. Y. Wong
Jovi. C. Y. Wong
YDYifei. J. Dong
Yifei. J. Dong
SBStephanie. L. Borgland
Stephanie. L. Borgland
Mesolimbic dopamine (DA) signaling has been implicated in the incentive, reinforcing and motivational aspects of food intake. Insulin receptors are expressed on dopaminergic neurons of the ventral tegmental area (VTA), and insulin may act in the VTA to suppress feeding. However, the neural mechanisms underlying insulin effects in the VTA are poorly understood. Here, we measured the effects of insulin on evoked DA concentration in the VTA using fast‐scan cyclic voltammetry. Insulin concentration‐dependently reduced evoked somatodendritic DA in the VTA, requiring activation of phosphoinositol 3‐kinase and mTOR signaling. Insulin depression of somatodendritic DA was abolished in the presence of a selective DA transporter (DAT) inhibitor, GBR 12909, as well as in VTA slices of DAT knockout mice, suggesting that insulin upregulated the number or function of DAT to reduce DA concentration. Finally, insulin administered to the VTA depressed sated feeding of sweetened high‐fat food. Taken together, these results indicate that insulin depresses DA concentration in the VTA via increased reuptake of DA through DAT. Insulin‐mediated decrease of DA in the VTA may suppress salience of food once satiety is reached.

18 February 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
YDYifei Dong
Yifei Dong
CDCharlotte D’mEllo
Charlotte D’mEllo
WPWilliam Pinsky
William Pinsky
BLBrian M. Lozinski
Brian M. Lozinski
DKDeepak K. Kaushik
Deepak K. Kaushik
VYV. Wee Yong
V. Wee Yong

14 April 2015 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
SLSally S. M. Lee-Sayer
Sally S. M. Lee-Sayer
YDYifei Dong
Yifei Dong
AAArif A. Arif
Arif A. Arif
MOMia Olsson
Mia Olsson
KBKelly L. Brown
Kelly L. Brown
PJPauline Johnson
Pauline Johnson
Hyaluronan is made and extruded from cells to form a pericellular or extracellular matrix (ECM) and is present in virtually all tissues in the body. The size and form of hyaluronan present in tissues is indicative of a healthy or inflamed tissue, and the interactions of hyaluronan with immune cells can influence their response. Thus in order to understand how inflammation is regulated, it is necessary to understand these interactions and their consequences. Although there is a large turnover of hyaluronan in our bodies, the large molecular mass form of hyaluronan predominates in healthy tissues. Upon tissue damage and/or infection, the ECM and hyaluronan are broken down and an inflammatory response ensues. As inflammation is resolved, the ECM is restored and high molecular mass hyaluronan predominates again. Immune cells encounter hyaluronan in the tissues and lymphoid organs and respond differently to high and low molecular mass forms. Immune cells differ in their ability to bind hyaluronan and this can vary with the cell type and their activation state. For example, peritoneal macrophages do not bind soluble hyaluronan but can be induced to bind after exposure to inflammatory stimuli. Likewise, naïve T cells, which typically express low levels of CD44, the hyaluronan receptor, do not bind hyaluronan until they undergo antigen-stimulated T cell proliferation and upregulate CD44. Despite substantial knowledge of where and when immune cells bind hyaluronan, why immune cells bind hyaluronan remains a major outstanding question. Here, we review what is currently known about the interactions of hyaluronan with immune cells in both healthy and inflamed tissues and discuss how hyaluronan binding by immune cells influences the inflammatory response.

16 September 2019 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
YDYifei Dong
Yifei Dong
VYV. Wee Yong
V. Wee Yong

12 May 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
Kannan NagarajanKannan Nagarajan
Kannan Nagarajan
Long NguyenLong Nguyen
Long Nguyen
MMMaisam Makarem
Maisam Makarem
YDYifei Dong
Yifei Dong
KSKingsley Shih
Kingsley Shih
CEConnie J. Eaves
Connie J. Eaves
Significance: Our study reveals lineage-specific mechanisms of ROS control and associated sensitivity to oxidative DNA damage in the basal and luminal progenitor-enriched subsets of normal human mammary cells. We show that the primitive luminal cells contain more mitochondria, show greater uptake of O 2 , sustain and withstand higher levels of ROS, and have mechanisms that allow them to accrue mutagenic levels of oxidative DNA damage. These findings support a growing body of data suggesting the involvement of primitive luminal cells in the generation of human breast cancers.